Abstract
-
(1)
The role of conjugating enzymes is best understood by looking at the interaction between phase I (mostly cytochromes P-450) and phase II (conjugation) enzymes of drug metabolism. A balance between phase I and II enzymes of detoxication largely determines the disposition to drug toxicity. Reactive electrophilic metabolites, generated by phase I enzymes, are often controlled by GSH-tansferases, whereas nucleophilic metabolites such as phenols are controlled by UDP-glucuronosyltransferases (GT) and sulfotransferases. It is more and more recognized that the control of the more stable and more abundant nucleophiles is as important as the control of electrophiles, since the former can be readily converted to electrophiles. For example, phenols and quinols can undergo quinone/quinol redox-cycles with the generation of reactive oxygen species. In the case of benzo(a)pyrene-3,6-quinol toxicity can be prevented by glucuronidation.
-
(2)
Conjugating enzymes consist of families of isoenzymes with distinct but overlapping substrate specificity. Rather than dealing with individual isoenzymes, adaptive programs are emphasized by which gene expression of a battery of phase I and II enzymes is turned on by certain types of inducing agents. Mechanistically best known is the program turned on by 3-methylcholanthrene-type inducers which includes enhanced synthesis of certain isoenzymes of cytochrom P-450, GT and probably GSH-transferase. The program may adapt the organism to efficiently detoxify and eliminate aromatic compounds such as benzo(a)pyrene. Evidence is presented that this program exists in both rodents and humans.
-
(3)
The balance between phase I and II enzymes is permanently altered after initiation of hepatocarcinogenesis. Cytochromes P-450 are decreased both in liver foci of altered hepatocytes and nodules, whereas GTs and GSH-transferases are increased. The altered enzyme pattern is consistent with increased toxin resistance of initiated hepatocytes. This toxin-resistance phenotype leads to selective growth of initiated hepatocytes during continuous exposure to carcinogens and may thus facilitate the evolution of cancer cells.
Similar content being viewed by others
References
Aström A, DePierre JW, Eriksson L (1983) Characterization of drug-metabolizing systems in hyperplastic nodules from the livers of rats receiving 2-acetylaminofluorene in their diet. Carcinogenesis 4: 577–581
Blumberg BS, London WT (1985) Hepatitis B virus and the prevention of primary cancer of the liver. J Natl Cancer Inst 74: 267–273
Bock KW, Fröhling W, Remmer H, Rexer B (1973) Effects of phenobarbital and 3-methylcholanthrene on substrate specificity of rat liver microsomal UDP-glucuronyltransferase. Biochim Biophys Acta 327: 46–56
Bock KW, Josting D, Lilienblum W, Pfeil H (1979) Purification of rat liver microsomal UDP-glucuronyltransferase. Eur J Biochem 98: 19–26
Bock KW, Bock-Hennig BS, Lilienblum W, Volp RF (1981) Release of mutagenic metabolites of benzo(a)pyrene from the perfused rat liver after inhibition of glucuronidation and sulfation by salicylamide. Chem Biol Interact 36: 167–177
Bock KW, Lilienblum W, Pfeil H (1982a) Functional heterogeneity of UDP-glucuronosyltransferase activities in C57BL/6 and DBA/2 mice. Biochem Pharmacol 31: 1273–1277
Bock KW, Lilienblum W, Pfeil H, Eriksson LC (1982b) Increased UDP-glucuronyltransferase activity in preneoplastic liver nodules and Morris hepatomas. Cancer Res 42: 3747–3752
Bock KW, Lilienblum W, Ullrich D, Fischer G (1984) Differential induction of UDP-glucuronosyltransferases and their “permanent induction” in preneoplastic rat liver. Biochem Soc Trans 12:55–58
Burchell B (1979) Purification of mouse liver UDP-glucuronosyltransferase. Med Biol 57: 265–268
Cameron R, Sweeney GD, Jones K, Lee G, Farber E (1976) A relative deficiency of cytochrome P-450 and arylhydrocarbon (benzo(a)pyrene) hydroxylase in hyperplastic nodules induced by 2-acetylaminofluorene in rat liver. Cancer Res 36: 3888–3893
Conney AH, Miller EC, Miller JA (1956) The metabolism of methylated aminoazo dyes. V. Evidence for induction of enzyme synthesis in the rat by 3-methylcholanthrene. Cancer Res 16: 450–459
Del Villar E, Sanchez E, Autor AP Tephly TR (1974) Morphine metabolism. III. Solubilization and separation of morphine and p-nitrophenol uridine diphosphoglucuronyltransferases. Mol Pharmacol 11: 236–240
Falany CN, Kirkpatrick RB, Tephly TR (1985) Comparison of rat and rabbit liver UDP-glucuronosyltransferase activities. In: Matern S, Bock KW, Gerok W (eds) Advances in glucuronide conjugation. MTP Press, Lancaster, pp 41–49
Farber E (1984) Cellular biochemistry of the stepwise development of cancer with chemicals. Cancer Res 44: 5463–5474
Felton JS, Ketley JN, Jakoby WB, Aitio A, Bend JR, Nebert DW (1980) Hepatic glutathione transferase activity induced by polycyclic aromatic compounds. Mol Pharmacol 18: 559–564
Fischer G, Ullrich D, Katz N, Bock KW, Schauer A (1983a) Immunohistochemical and biochemical detection of uridine-diphosphate-glucuronyltransferase (UDP-GT) activity in putative preneoplastic liver foci. Virchows Arch 42: 193–200
Fischer G, Schauer A, Bock KW, Ullrich D, Katz NR (1983b) Immunohistochemical demonstration of increased UDP-glucuronyltransferase in putative preneoplastic liver foci. Naturwissenschaften 70: 153–154
Fischer G, Ullrich D, Bock KW (1985a) Effects of N-nitrosomorpholine and phenobarbital on UDP-glucuronyltransferase in putative preneoplastic foci of rat liver. Carcinogenesis 6: 605–609
Fischer G, Schauer A, Hartmann H, Bock KW (1985b) Increased UDP-glucuronyltransferase in putative preneoplastic foci of human liver after long-term use of oral contraceptives. Naturwissenschaften 72: 277–289
Fleischmann R, Stärz U, Remmer H (1985) Increased activity of certain isoenzymes of cytochrome P-450 and UDP-glucuronyltransferases in the liver of cigarette smokers. in: Matern S, Bock KW, Gerok W (eds) Advances in glucuronide conjugation. MTP Press, Lancaster, pp 351–365
Gibby EM, D'Arcy Doherty M, Cohen GM (1985) Alterations in glucuronic acid and sulphate ester conjugation in normal and tumour tissues. In: Matern S, Bock KW, Gerok W (eds) Advances in glucuronide conjugation. MTP Press, Lancaster, pp 317–326
Glatt HR, Platt KL, Vogel K, Bücker M, Billings R, Oesch F (1980) Metabolie inactivation of mutagenic benzo(a)pyrene metabolites: Significance to carcinogenicity and implications for in vivo tests. In: Holmstedt B, Lauwerys R, Mercier M, Roberfroid M (eds) Mechanisms of toxicity and hazard evaluation. Elsevier/North-Holland, pp 181–186
Jakoby WB, Sekura RD, Lyon ES, Marcus CJ, Wang JL (1980) Sulfotransferases. In: Jakoby WB (ed) Enzymatic basis of detoxication, vol. 2. Academic Press, New York, London, Toronto, Sydney, San Francisco, pp 199–228
Jakoby WB, Ketterer B, Mannervik B (1984) Glutathione transferases: Nomenclature. Biochem Pharmacol 33: 2539–2540
Land H, Parada LF, Weinberg RA (1983) Cellular oncogenes and multistep carcinogenesis. Science 222: 771–778
Lilienblum W, Bock-Hennig BS, Bock KW (1985) Protection against toxic redox-cycles between benzo(a)pyrene-3,6-quinone and its quinol by 3-methylcholanthrene-inducible formation of the quinol mono- and diglucuronide. Mol Pharmacol 27: 451–458
Lorentzen RJ, Ts'o POP (1977) Benzo(a)pyrenedione/benzo(a)-pyrenediol oxidation-reduction couples and the generation of reactive reduced molecular oxygen. Biochemistry 16: 1467–1473
Lorentzen RJ, Lesko SA, McDonald K, Ts'o POP (1979) Toxicity of metabolic benzo(a)pyrenediones to cultured cells and the dependence upon molecular oxygen. Cancer Res 39: 3194–3198
Lu AYH, West SB (1980) Multiplicity of mammalian microsomal cytochromes P-450. Pharmacol Rev 31: 277–295
Lueders KK, Dyer HM, Thompson EB, Kuff EL (1979) Glucuronyltransferase activity in transplantable rat hepatomas. Cancer Res 30: 274–279
Mackenzie PI, Gonzalez FJ, Owens IS (1984) Cloning and characterization of DNA complementary to rat liver UDP-glucuronosyltransferase mRNA. J Biol Chem 259: 12153–12158
Mackenzie PI, Owens IS (1984) Cleavage of nascent UDP glucuronosyltranserase from rat liver by dog pancreatic microsomes. Biochem Biophys Res Commun 122: 1441–1449
Malaveille C, Brun G, Hautefeuille A, Bartsch H (1980) Effect of glutathione and uridine 5′-diphosphoglucuronic acid on benzo(a)pyrene mutagenesis in the salmonella/microsome assay. In: Holmstedt B, Lauwerys R, Mercier M, Roberfroid M (eds) Mechanisms of toxicity and hazard evaluation. Elsevier/North-Holland, pp 175–180
Miller EC, Miller JA (1981) Searches for ultimate chemical carciogens and their reactions with cellular macromolecules. Cancer 47: 2327–2345
Miners JO, Attwood J, Birkett DJ (1984) Determinants of acetaminophen metabolism: Effect of inducers and inhibitors of drug metabolism on acetaminophen's metabolic pathways. Clin Pharmacol Ther 35: 480–486
Mucklow JC, Fraser HS, Bulpitt CJ, Kahn C, Mould G, Dollery CT (1980) Environmental factors affecting paracetamol metabolism in London factory and office workers. Br J Clin Pharmac 10: 67–74
Nebert DW, Jensen NM (1979) The Ah locus: genetic regulation of the metabolism of carcinogens, drugs, and other environmental chemicals by cytochrome P-450-mediated monooxygenases. CRC Crit Rev Biochem 6: 401–437
Owens IS (1977) Genetic regulation of UDP-glucuronosyltransferase induction by polycyclic aromatic compounds in mice. J Biol Chem 252: 2827–2833
Pfeil H, Bock KW (1983) Electroimmunochemical quantification of UDP-glucuronosyltransferase in rat liver microsomes. Eur J Biochem 131: 619–623
Pickett CB, Telakowski-Hopkins CA, Ding GJF, Argenbright L and Lu AYH (1984a) Rat liver glutathione S-transferases. J Biol Chem 259: 5182–5188
Pickett CB, Williams JB, Lu AYH, Cameron RG (1984b) Regulation of glutathione transferase and DT-diaphorase mRNAs in persistant hepatocyte nodules during chemical carcinogenesis. Proc Natl Acad Sci USA 81: 5091–5095
Pitot HC, Peraino C, Morse PA Jr, Potter VR (1964) Hepatomas in tissue culture compared with adapting liver in vivo. Natl Cancer Inst Monogr 13: 229–242
Pitot HC, Sirica AE (1980) The stages of initiation and promotion in hepatocarcinogenesis. Biochim Biophys Acta 605: 191–215
Poland A, Glover E and Kende AS (1976) Stereospecific high affinily binding of 2, 3, 7, 8-tetrachlorodibenzo-p-dioxin by hepatic cytosol. J Biol Chem 251: 4936–4946
Prescott LF (1980) Kinetics and metabolism of paracetamol and phenacetin. Br J Clin Pharmacol 10: 291S-298S
Remmer H, Alsleben B (1958) Die Aktivierung der Entgiftung in den Lebermikrosomen während der Gewöhnung. Klin Wschr 36: 332–333
Reuber MD (1961) A transplantable bile-secreting hepatocellular carcinoma in the rat. J Natl Cancer Inst 26: 891–898
Roy Chowdhury J, Roy Chowdhury N, Novikoff PM, Novikoff AB, Arias IM (1985) UDP-glucuronyltransferase: problems within a biological “family”. In: Matern S, Bock KW, Gerok W (eds) Advances in glucuronide conjugation. MTP Press, Lancaster, pp 33–40
Scherer E (1984) Neoplastic progression in experimental hepatocarcinogenesis. Biochim Biophys Acta 738: 219–236
Scragg I, Celier C, Burchell B (1985) Congenital jaundice in rats due to the absence of hepatic bilirubin UDP-glucuronyltransferase enzyme protein. FEBS Lett 183: 37–42
Solt D, Farber E (1976) New principle for the analysis of chemical carcinogenesis. Nature 263: 701–703
Ullrich D, Fischer G, Katz N, Bock KW (1984) Intralobular distribution of UDP-glucuronosyltransferase in livers from untreated, 3-methylcholanthrene- and phenobarbital-treated rats. Chem Biol Interact 48: 181–190
Weber WW, Hein DW (1985) N-acetylation pharmacokinetics. Pharmacol Rev 37: 25–79
Wiltfang J, Blume R, Bock KW (1986) Increased paracetamol glucuronidation in smokers and in patients taking phenytoin or rifampicin. Naunyn-Schmiedeberg's Arch. Pharmacol 332, R 95
Wishart GJ (1978) Demonstration of functional heterogeneity of hepatic uridine diphosphate glucuronosyltransferase activities after administration of 3-methylcholanthrene and phenobarbital to rats. Biochem J 174: 671–672
Yin Z, Sato K, Tsuda H, Ito N (1982) Changes in activities of uridine diphosphate-glucuronyltransferase during chemical hepatocarcinogenesis. Gann 73: 239–248
Author information
Authors and Affiliations
Additional information
Dedicated to Professor Dr. med Herbert Remmer on the occasion of his 65th birthday
Rights and permissions
About this article
Cite this article
Bock, K.W., Lilienblum, W., Fischer, G. et al. The role of conjugation reactions in detoxication. Arch Toxicol 60, 22–29 (1987). https://doi.org/10.1007/BF00296941
Issue Date:
DOI: https://doi.org/10.1007/BF00296941